Cargando…
May Long Term Oxcarbazepine Treatment Be Lead to Secondary Hyperparathyroidism?
BACKGROUND AND PURPOSE: The adverse effects of newer antiepileptic drugs are not well-known. This study assessed the impact of oxcarbazepine (OXC) treatment on bone turnover. METHODS: Forty-four children with idiopathic focal (and/or secondarily generalized) epilepsy who had been treated with OXC fo...
Autores principales: | Babacan, O., Karaoglu, A., Vurucu, S., Yesilkaya, E., Yesilyurt, O., Cayci, T., Gulgun, M., Unay, B., Akın, R., Ozcan, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325434/ https://www.ncbi.nlm.nih.gov/pubmed/22523515 http://dx.doi.org/10.3988/jcn.2012.8.1.65 |
Ejemplares similares
-
Desensitization to Oxcarbazepine: Long-Term Efficacy and Tolerability
por: Lee, Jiwon, et al.
Publicado: (2017) -
Oxcarbazepine May Be Useful in Sydenham Chorea
por: Işıkay, Sedat, et al.
Publicado: (2021) -
Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022) -
Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
por: Jung, Gu Hyun, et al.
Publicado: (2019) -
Oxcarbazepine Therapy for Complete Central Diabetes Insipidus
por: Abdallah, Basmah, et al.
Publicado: (2018)